| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.27 | 4e-14 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | 0.34 | 3e-11 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | 0.22 | 1e-08 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.2 | 4e-08 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | 0.34 | 4e-07 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-06 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.17 | 2e-06 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.15 | 3e-06 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | -0.16 | 4e-06 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.21 | 4e-06 |